Cumberland Pharmaceuticals Inc. Selling and Marketing Expense
Cumberland Pharmaceuticals Inc. (CPIX) reported Selling and Marketing Expense of $5.06 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-05-08
- Cumberland Pharmaceuticals Inc. selling and marketing expense for the quarter ending 2026-03-31 was $5.06M, a 19.68% increase year-over-year.
- Cumberland Pharmaceuticals Inc. selling and marketing expense for the quarter ending 2025-12-31 was $6.21M, a 47.04% increase year-over-year.
- Cumberland Pharmaceuticals Inc. selling and marketing expense for the quarter ending 2025-09-30 was $4.43M, a 0.83% increase year-over-year.
- Cumberland Pharmaceuticals Inc. selling and marketing expense for the quarter ending 2025-06-30 was $4.22M, a 0.58% decline year-over-year.
- Cumberland Pharmaceuticals Inc. selling and marketing expense for fiscal 2025 was $19.10M, a 12.19% increase from fiscal 2024.
- Cumberland Pharmaceuticals Inc. selling and marketing expense for fiscal 2024 was $17.02M, a 7.74% decline from fiscal 2023.
- Cumberland Pharmaceuticals Inc. selling and marketing expense for fiscal 2023 was $18.45M, a 10.75% increase from fiscal 2022.
- Cumberland Pharmaceuticals Inc. selling and marketing expense for fiscal 2022 was $16.66M, a 10.96% increase from fiscal 2021.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 3 month as first filed | Selling and Marketing Expense 6 month | Selling and Marketing Expense 6 month as first filed | Selling and Marketing Expense 9 month | Selling and Marketing Expense 9 month as first filed | Selling and Marketing Expense 12 month | Selling and Marketing Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $5.06M 10-Q · filed 2026-05-08 | $11.27M derived: sum of 2 quarters · filed 2026-05-08 | $15.71M derived: sum of 3 quarters · filed 2026-05-08 | $19.93M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2025-12-31 | $6.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $10.64M derived: sum of 2 quarters · filed 2026-03-09 | $14.87M derived: sum of 3 quarters · filed 2026-03-09 | $19.10M 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | $4.43M 10-Q · filed 2025-11-07 | $8.66M derived: sum of 2 quarters · filed 2025-11-07 | $12.89M 10-Q · filed 2025-11-07 | $17.11M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2025-06-30 | $4.22M 10-Q · filed 2025-08-08 | $8.46M 10-Q · filed 2025-08-08 | $12.68M derived: sum of 3 quarters · filed 2026-05-08 | $17.08M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2025-03-31 | $4.23M 10-Q · filed 2026-05-08 | $8.45M derived: sum of 2 quarters · filed 2026-05-08 | $12.85M derived: sum of 3 quarters · filed 2026-05-08 | $17.10M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | $4.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $8.62M derived: sum of 2 quarters · filed 2026-03-09 | $12.87M derived: sum of 3 quarters · filed 2026-03-09 | $17.02M 10-K · filed 2026-03-09 | ||||
| 2024-09-30 | $4.40M 10-Q · filed 2025-11-07 | $8.65M derived: sum of 2 quarters · filed 2025-11-07 | $12.80M 10-Q · filed 2025-11-07 | $17.56M derived: sum of 4 quarters · filed 2025-11-07 | ||||
| 2024-06-30 | $4.25M 10-Q · filed 2025-08-08 | $8.40M 10-Q · filed 2025-08-08 | $13.16M derived: sum of 3 quarters · filed 2025-08-08 | $17.91M derived: sum of 4 quarters · filed 2025-08-08 | ||||
| 2024-03-31 | $4.15M 10-Q · filed 2025-05-09 | $8.91M derived: sum of 2 quarters · filed 2025-05-09 | $13.66M derived: sum of 3 quarters · filed 2025-05-09 | $18.33M derived: sum of 4 quarters · filed 2025-05-09 | ||||
| 2023-12-31 | $4.76M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $9.50M derived: sum of 2 quarters · filed 2025-03-07 | $14.17M derived: sum of 3 quarters · filed 2025-03-07 | $18.45M 10-K · filed 2025-03-07 | ||||
| 2023-09-30 | $4.74M 10-Q · filed 2024-11-08 | $9.42M derived: sum of 2 quarters · filed 2024-11-08 | $13.69M 10-Q · filed 2024-11-08 | $17.07M derived: sum of 4 quarters · filed 2024-11-08 | ||||
| 2023-06-30 | $4.67M 10-Q · filed 2024-08-09 | $8.95M 10-Q · filed 2024-08-09 | $12.33M derived: sum of 3 quarters · filed 2024-08-09 | $16.44M derived: sum of 4 quarters · filed 2024-08-09 | ||||
| 2023-03-31 | $4.28M 10-Q · filed 2024-05-10 | $7.66M derived: sum of 2 quarters · filed 2024-05-10 | $11.77M derived: sum of 3 quarters · filed 2024-05-10 | $16.32M derived: sum of 4 quarters · filed 2024-05-10 | ||||
| 2022-12-31 | $3.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $7.49M derived: sum of 2 quarters · filed 2024-03-13 | $12.05M derived: sum of 3 quarters · filed 2024-03-13 | $16.66M 10-K · filed 2024-03-13 | ||||
| 2022-09-30 | $4.11M 10-Q · filed 2023-11-13 | $8.67M derived: sum of 2 quarters · filed 2023-11-13 | $13.28M 10-Q · filed 2023-11-13 | $16.59M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $4.56M 10-Q · filed 2023-08-11 | $9.17M 10-Q · filed 2023-08-11 | $12.48M derived: sum of 3 quarters · filed 2023-08-11 | $16.28M derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | $4.61M 10-Q · filed 2023-05-12 | $7.92M derived: sum of 2 quarters · filed 2023-05-12 | $11.72M derived: sum of 3 quarters · filed 2023-05-12 | $15.84M derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | $3.31M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $7.11M derived: sum of 2 quarters · filed 2023-03-13 | $11.23M derived: sum of 3 quarters · filed 2023-03-13 | $15.02M 10-K · filed 2023-03-13 | ||||
| 2021-09-30 | $3.80M 10-Q · filed 2022-11-14 | $7.92M derived: sum of 2 quarters · filed 2022-11-14 | $11.71M 10-Q · filed 2022-11-14 | $15.31M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $4.12M 10-Q · filed 2022-08-12 | $7.91M 10-Q · filed 2022-08-12 | $11.51M derived: sum of 3 quarters · filed 2022-08-12 | $15.10M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $3.79M 10-Q · filed 2022-05-13 | $7.39M derived: sum of 2 quarters · filed 2022-05-13 | $10.98M derived: sum of 3 quarters · filed 2022-05-13 | $14.85M derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | $3.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $7.19M derived: sum of 2 quarters · filed 2022-03-11 | $11.06M derived: sum of 3 quarters · filed 2022-03-11 | $14.77M 10-K · filed 2022-03-11 | ||||
| 2020-09-30 | $3.59M 10-Q · filed 2021-11-12 | $7.45M derived: sum of 2 quarters · filed 2021-11-12 | $11.16M 10-Q · filed 2021-11-12 | $15.21M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2020-06-30 | $3.87M 10-Q · filed 2021-08-13 | $7.57M 10-Q · filed 2021-08-13 | $11.62M derived: sum of 3 quarters · filed 2022-03-11 | $15.43M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2020-03-31 | $3.71M 10-Q · filed 2021-05-14 | $7.75M derived: sum of 2 quarters · filed 2022-03-11 | $11.57M derived: sum of 3 quarters · filed 2022-03-11 | $15.55M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2019-12-31 | $4.05M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $7.86M derived: sum of 2 quarters · filed 2022-03-11 | $11.84M derived: sum of 3 quarters · filed 2022-03-11 | $15.28M 10-K · filed 2022-03-11 | $21.43M 10-K · filed 2020-03-20 | |||
| 2019-09-30 | $3.81M 10-Q · filed 2020-11-13 | $5.56M 10-Q · filed 2019-11-13 | $7.79M derived: sum of 2 quarters · filed 2020-11-13 | $11.23M 10-Q · filed 2020-11-13 | $15.84M 10-Q · filed 2019-11-13 | $10.69M derived: sum of 4 quarters · filed 2021-03-12 | ||
| 2019-06-30 | $3.98M 10-Q · filed 2020-08-14 | $5.15M 10-Q · filed 2019-08-14 | $7.42M 10-Q · filed 2020-08-14 | $10.27M 10-Q · filed 2019-08-14 | $6.87M derived: sum of 3 quarters · filed 2021-03-12 | $11.68M derived: sum of 4 quarters · filed 2021-03-12 | ||
| 2019-03-31 | $3.44M 10-Q · filed 2020-05-22 | $5.12M 10-Q · filed 2019-05-15 | $2.89M derived: sum of 2 quarters · filed 2021-03-12 | $7.70M derived: sum of 3 quarters · filed 2021-03-12 | $12.77M derived: sum of 4 quarters · filed 2021-03-12 | |||
| 2018-12-31 | -$544.94K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $4.26M derived: sum of 2 quarters · filed 2021-03-12 | $9.33M derived: sum of 3 quarters · filed 2021-03-12 | $14.00M 10-K · filed 2021-03-12 | $20.26M 10-K · filed 2019-03-12 | |||
| 2018-09-30 | $4.80M 10-Q · filed 2019-11-13 | $9.88M derived: sum of 2 quarters · filed 2019-11-13 | $14.55M 10-Q · filed 2019-11-13 | $11.86M derived: sum of 4 quarters · filed 2020-12-10 | ||||
| 2018-06-30 | $5.08M 10-Q · filed 2019-08-14 | $9.75M 10-Q · filed 2019-08-14 | $7.06M derived: sum of 3 quarters · filed 2020-12-10 | $13.29M derived: sum of 4 quarters · filed 2020-12-10 | ||||
| 2018-03-31 | $4.67M 10-Q · filed 2019-05-15 | $1.99M derived: sum of 2 quarters · filed 2020-12-10 | $8.21M derived: sum of 3 quarters · filed 2020-12-10 | $12.87M derived: sum of 4 quarters · filed 2020-12-10 | ||||
| 2017-12-31 | -$2.69M derived: 8-K 12 month − 10-Q 9 month · filed 2020-12-10 | $3.54M derived: sum of 2 quarters · filed 2020-12-10 | $8.20M derived: sum of 3 quarters · filed 2020-12-10 | $13.49M 8-K · filed 2020-12-10 | $21.49M 10-K · filed 2018-03-09 | |||
| 2017-09-30 | $6.23M 10-Q · filed 2018-11-14 | $10.88M derived: sum of 2 quarters · filed 2018-11-14 | $16.17M 10-Q · filed 2018-11-14 | $20.14M derived: sum of 4 quarters · filed 2019-03-12 | ||||
| 2017-06-30 | $4.65M 10-Q · filed 2018-08-14 | $9.95M 10-Q · filed 2018-08-14 | $13.92M derived: sum of 3 quarters · filed 2019-03-12 | $17.53M derived: sum of 4 quarters · filed 2019-03-12 | ||||
| 2017-03-31 | $5.29M 10-Q · filed 2018-05-09 | $9.26M derived: sum of 2 quarters · filed 2019-03-12 | $12.88M derived: sum of 3 quarters · filed 2019-03-12 | $16.15M derived: sum of 4 quarters · filed 2019-03-12 | ||||
| 2016-12-31 | $3.97M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $7.58M derived: sum of 2 quarters · filed 2019-03-12 | $10.85M derived: sum of 3 quarters · filed 2019-03-12 | $14.55M 10-K · filed 2019-03-12 | ||||
| 2016-09-30 | $3.61M 10-Q · filed 2017-11-08 | $6.89M derived: sum of 2 quarters · filed 2017-11-08 | $10.59M 10-Q · filed 2017-11-08 | $13.94M derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2016-06-30 | $3.27M 10-Q · filed 2017-08-09 | $6.97M 10-Q · filed 2017-08-09 | $10.32M derived: sum of 3 quarters · filed 2018-03-09 | $13.93M derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2016-03-31 | $3.70M 10-Q · filed 2017-05-15 | $7.05M derived: sum of 2 quarters · filed 2018-03-09 | $10.66M derived: sum of 3 quarters · filed 2018-03-09 | $14.16M derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2015-12-31 | $3.35M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $6.96M derived: sum of 2 quarters · filed 2018-03-09 | $10.46M derived: sum of 3 quarters · filed 2018-03-09 | $13.99M 10-K · filed 2018-03-09 | ||||
| 2015-09-30 | $3.61M 10-Q · filed 2016-11-03 | $7.11M derived: sum of 2 quarters · filed 2016-11-03 | $10.65M 10-Q · filed 2016-11-03 | $14.18M derived: sum of 4 quarters · filed 2017-03-13 | ||||
| 2015-06-30 | $3.51M 10-Q · filed 2016-08-05 | $7.04M 10-Q · filed 2016-08-05 | $10.57M derived: sum of 3 quarters · filed 2017-03-13 | $14.39M derived: sum of 4 quarters · filed 2017-03-13 | ||||
| 2015-03-31 | $3.53M 10-Q · filed 2016-05-13 | $7.07M derived: sum of 2 quarters · filed 2017-03-13 | $10.89M derived: sum of 3 quarters · filed 2017-03-13 | $14.82M derived: sum of 4 quarters · filed 2017-03-13 | ||||
| 2014-12-31 | $3.54M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $7.36M derived: sum of 2 quarters · filed 2017-03-13 | $11.29M derived: sum of 3 quarters · filed 2017-03-13 | $14.90M 10-K · filed 2017-03-13 | ||||
| 2014-09-30 | $3.82M 10-Q · filed 2015-11-06 | $7.75M derived: sum of 2 quarters · filed 2015-11-06 | $11.37M 10-Q · filed 2015-11-06 | $15.13M derived: sum of 4 quarters · filed 2016-03-14 | ||||
| 2014-06-30 | $3.93M 10-Q · filed 2015-08-07 | $7.54M 10-Q · filed 2015-08-07 | $11.31M derived: sum of 3 quarters · filed 2016-03-14 | $14.72M derived: sum of 4 quarters · filed 2016-03-14 | ||||
| 2014-03-31 | $3.61M 10-Q · filed 2015-05-15 | $7.38M derived: sum of 2 quarters · filed 2016-03-14 | $10.79M derived: sum of 3 quarters · filed 2016-03-14 | $14.33M derived: sum of 4 quarters · filed 2016-03-14 | ||||
| 2013-12-31 | $3.76M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $7.17M derived: sum of 2 quarters · filed 2016-03-14 | $10.71M derived: sum of 3 quarters · filed 2016-03-14 | $14.39M 10-K · filed 2016-03-14 | ||||
| 2013-09-30 | $3.41M 10-Q · filed 2014-11-07 | $6.95M derived: sum of 2 quarters · filed 2014-11-07 | $10.63M 10-Q · filed 2014-11-07 | $15.57M derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2013-06-30 | $3.54M 10-Q · filed 2014-08-08 | $7.22M 10-Q · filed 2014-08-08 | $12.16M derived: sum of 3 quarters · filed 2015-03-09 | $17.07M derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2013-03-31 | $3.67M 10-Q · filed 2014-05-12 | $8.62M derived: sum of 2 quarters · filed 2015-03-09 | $13.53M derived: sum of 3 quarters · filed 2015-03-09 | $19.02M derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2012-12-31 | $4.94M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $9.86M derived: sum of 2 quarters · filed 2015-03-09 | $15.35M derived: sum of 3 quarters · filed 2015-03-09 | $20.33M 10-K · filed 2015-03-09 | ||||
| 2012-09-30 | $4.91M 10-Q · filed 2013-11-06 | $10.41M derived: sum of 2 quarters · filed 2013-11-06 | $15.39M 10-Q · filed 2013-11-06 | $20.07M derived: sum of 4 quarters · filed 2014-03-11 | ||||
| 2012-06-30 | $5.49M 10-Q · filed 2013-08-09 | $10.47M 10-Q · filed 2013-08-09 | $15.16M derived: sum of 3 quarters · filed 2014-03-11 | $20.22M derived: sum of 4 quarters · filed 2014-03-11 | ||||
| 2012-03-31 | $4.98M 10-Q · filed 2013-05-08 | $9.67M derived: sum of 2 quarters · filed 2014-03-11 | $14.73M derived: sum of 3 quarters · filed 2014-03-11 | $20.63M derived: sum of 4 quarters · filed 2014-03-11 | ||||
| 2011-12-31 | $4.69M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $9.75M derived: sum of 2 quarters · filed 2014-03-11 | $15.65M derived: sum of 3 quarters · filed 2014-03-11 | $20.94M 10-K · filed 2014-03-11 | ||||
| 2011-09-30 | $5.06M 10-Q · filed 2012-11-02 | $10.96M derived: sum of 2 quarters · filed 2012-11-02 | $16.25M 10-Q · filed 2012-11-02 | $21.78M derived: sum of 4 quarters · filed 2013-03-12 | ||||
| 2011-06-30 | $5.90M 10-Q · filed 2012-08-09 | $11.19M 10-Q · filed 2012-08-09 | $16.72M derived: sum of 3 quarters · filed 2013-03-12 | $22.41M derived: sum of 4 quarters · filed 2013-03-12 | ||||
| 2011-03-31 | $5.29M 10-Q · filed 2012-05-04 | $10.82M derived: sum of 2 quarters · filed 2013-03-12 | $16.51M derived: sum of 3 quarters · filed 2013-03-12 | $22.36M derived: sum of 4 quarters · filed 2013-03-12 | ||||
| 2010-12-31 | $5.53M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $11.22M derived: sum of 2 quarters · filed 2013-03-12 | $17.07M derived: sum of 3 quarters · filed 2013-03-12 | $22.67M 10-K · filed 2013-03-12 | ||||
| 2010-09-30 | $5.69M 10-Q · filed 2011-11-07 | $11.54M derived: sum of 2 quarters · filed 2011-11-07 | $17.15M 10-Q · filed 2011-11-07 | |||||
| 2010-06-30 | $5.85M 10-Q · filed 2011-08-08 | $11.46M 10-Q · filed 2011-08-08 | ||||||
| 2009-12-31 | $20.19M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |